Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013, Article ID 104059, 8 pages
http://dx.doi.org/10.1155/2013/104059
Clinical Study

Cardiovascular and Renal Effects of Bromocriptine in Diabetic Patients with Stage 4 Chronic Kidney Disease

1Coordinación de Educación e Investigación en Salud, Unidad de Medicina Familiar No. 80, Instituto Mexicano del Seguro Social (IMSS), Morelia, Mich, Mexico
2Escuela Superior de Medicina, Instituto Politécnico Nacional, México, DF, Mexico
3Unidad de Investigación en Enfermedades Nefrológicas (IMSS), México, DF, Mexico
4Hospital General Regional No 1. (IMSS), Morelia, Mich, Mexico
5Divisions of Baxter Novum and Renal Medicine, Karolinska Institutet, Stockholm, Sweden

Received 29 April 2013; Revised 2 July 2013; Accepted 5 July 2013

Academic Editor: Vecihi Batuman

Copyright © 2013 Oliva Mejía-Rodríguez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [11 citations]

The following is the list of published articles that have cited the current article.

  • Cláudia Nogueira, Eduardo Vinha, Daniel Carvalho-Braga, Davide Carvalho, and Selma B. Souto, “Oral glucose lowering drugs in type 2 diabetic patients with chronic kidney disease,” Hormones, vol. 12, no. 4, pp. 483–494, 2013. View at Publisher · View at Google Scholar
  • Han Li, Su-Juan Feng, Gui-Zhi Zhang, and Shi-Xiang Wang, “Correlation of Lower Concentrations of Hydrogen Sulfide with Atherosclerosis in Chronic Hemodialysis Patients with Diabetic Nephropathy,” Blood Purification, vol. 38, no. 3-4, pp. 188–194, 2014. View at Publisher · View at Google Scholar
  • Alexander O Shpakov, Kira V Derkach, and Lev M Berstein, “Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases,” Future Science OA, pp. 1–29, 2015. View at Publisher · View at Google Scholar
  • Han Li, Su-Juan Feng, Lu-Lu Su, Wei Wang, Xiao-Dong Zhang, and Shi-Xiang Wang, “Serum Hepcidin Predicts Uremic Accelerated Atherosclerosis in Chronic Hemodialysis Patients with Diabetic Nephropathy,” Chinese Medical Journal, vol. 128, no. 10, pp. 1351–1357, 2015. View at Publisher · View at Google Scholar
  • Sofia B. Ahmed, and Sharanya Ramesh, “Sex hormones in women with kidney disease,” Nephrology Dialysis Transplantation, pp. gfw084, 2016. View at Publisher · View at Google Scholar
  • Mitra Niafar, Leili Pourafkari, Kavus Shahsavarinia, Nushin Milanchian, Farhad Niafar, and Nader Nader, “Effects of bromocriptine mesylate on homocysteine and high-sensitivity C-reactive protein levels in patients with type-2 diabetes mellitus,” Journal of Cardiovascular and Thoracic Research, vol. 8, no. 1, pp. 8–12, 2016. View at Publisher · View at Google Scholar
  • Susanne U. Miedlich, and Steven D. Wittlin, “19 Diabetes in Older Adults and Its Management,” Geriatric Rehabilitation, pp. 365–390, 2017. View at Publisher · View at Google Scholar
  • Ralf Westenfeld, Verena Stangl, Ingrid Kindermann, Uwe Kühl, Christiane E. Angermann, Dieter Fischer, Edith Podewski, Michael Böhm, Johann Bauersachs, Jens Vogel-Claussen, Annegret Franke, Roman Pfister, Denise Hilfiker-Kleiner, Guido Michels, Axel Schlitt, Arash Haghikia, Karen Sliwa, Dominik Berliner, Johannes Schwab, Marziel Schwarzkopf, and Philipp Ehlermann, “Bromocriptine for the treatment of peripartum cardiomyopathy: A multicentre randomized study,” European Heart Journal, vol. 38, no. 35, pp. 2671–2679, 2017. View at Publisher · View at Google Scholar
  • Machelle T. Pardue, and Rachael S. Allen, “Neuroprotective strategies for retinal disease,” Progress in Retinal and Eye Research, 2018. View at Publisher · View at Google Scholar
  • Deborah A. Chon, Rachael T. Oxman, Rashmi S. Mullur, and Jane Eileen Weinreb, “Diabetic Pharmacotherapies in Kidney Disease,” Endocrine Disorders in Kidney Disease, pp. 49–74, 2019. View at Publisher · View at Google Scholar
  • Tamami Oshige, Yui Nakamura, Yuko Sasaki, Seiko Kawano, Tsuyoshi Ohki, Munehisa Tsuruta, Ichiro Tokubuchi, Hitomi Nakayama, Kentaro Yamada, Kenji Ashida, Yuji Tajiri, and Masatoshi Nomura, “Bromocriptine as a Potential Glucose-lowering Agent for the Treatment of Prolactinoma with Type 2 Diabetes,” Internal Medicine, 2020. View at Publisher · View at Google Scholar